The expression of PAR1 on breast cancer cells causes a loss of epithelial markers such as E-cadherin and gain of mesenchymal markers including vimentin, shifting them to an invasive phenotype and allowing a HMG2A mediated invasion of breast cancer [225]. Here, VIM is linked to breast cancer.